1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase
(
- Contribution to journal › Article
-
Mark
Cohort profile : the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)
(
- Contribution to journal › Article
-
Mark
Preclinical Protein Signatures of Crohn's Disease and Ulcerative Colitis : A Nested Case-Control Study Within Large Population-Based Cohorts
(
- Contribution to journal › Article
- 2024
-
Mark
Hälsorelaterad livskvalitet vid inflammatorisk tarmsjukdom
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
- 2022
-
Mark
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases : A Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Association Between Inflammatory Bowel Disease and Spondyloarthritis : Findings from a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
- 2020
-
Mark
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis : results from a nationwide study in Sweden
(
- Contribution to journal › Article